David Shapiro

2012

In 2012, David Shapiro earned a total compensation of $1.4M as Chief Medical Officer and Executive Vice President, Development at Intercept Pharmaceuticals, a 147% increase compared to previous year.

Compensation breakdown

Bonus$16,953
Non-Equity Incentive Plan$123,047
Option Awards$308,326
Salary$375,000
Stock Awards$558,161
Other$13,621
Total$1,395,108

Shapiro received $558.2K in stock awards, accounting for 40% of the total pay in 2012.

Shapiro also received $17K in bonus, $123K in non-equity incentive plan, $308.3K in option awards, $375K in salary and $13.6K in other compensation.

Rankings

In 2012, David Shapiro's compensation ranked 4,833rd out of 11,487 executives tracked by ExecPay. In other words, Shapiro earned more than 57.9% of executives.

ClassificationRankingPercentile
All
4,833
out of 11,487
58th
Division
Manufacturing
1,687
out of 4,253
60th
Major group
Chemicals And Allied Products
395
out of 1,198
67th
Industry group
Drugs
251
out of 920
73rd
Industry
Pharmaceutical Preparations
197
out of 700
72nd
Source: SEC filing on April 12, 2013.

Shapiro's colleagues

We found two more compensation records of executives who worked with David Shapiro at Intercept Pharmaceuticals in 2012.

2012

Mark Pruzanski

Intercept Pharmaceuticals

Chief Executive Officer

2012

Barbara Duncan

Intercept Pharmaceuticals

Chief Financial Officer

You may also like